secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACTAVIA LIFE SCIENCES, INC. (—)
CIK:        0001582249
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001013762-23-006718
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rasna Therapeutics changes name to Actavia Life Sciences, Inc.
--------------------------------------------------------------

- Filed Certificate of Amendment with Nevada on October 24, 2023, changing corporate name to Actavia Life Sciences, Inc.
- Name change effective immediately upon filing; ticker symbol remains RASP on OTC Pink.
- No other amendments to articles or financial impact disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582249/000101376223006718/0001013762-23-006718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582249/000101376223006718/ea187278-8k_actavialife.htm
  HTML page:      https://secwatch.observer/filing/0001013762-23-006718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer